Table 3 CAP pathogens and treatments administered
Outpatientsa N=340 | Inpatients N=241 | Total N=581 | p | |
|---|---|---|---|---|
Microbiological study | ||||
Non-studied, n | 221 | 0 | 221 | |
Studied, n | 119 | 241 | 360 | |
Negative, n | 47 | 127 | 174 | |
Pathogen identified, n | 72 | 114 | 186 | |
Streptococcus pneumoniae | 25 | 82 | 107 | <0.001 |
Influenza virus type A | 41 | 9 | 50 | |
Legionella pneumophila | 5 | 8 | 13 | |
Haemophilus influenzae | 1 | 3 | 4 | |
Staphylococcus aureus | 0 | 3 | 3 | |
Pseudomonas aeruginosa | 0 | 3 | 3 | |
Other pathogens | 0 | 6 | 6 | |
Treatments, % | ||||
Quinolones | 52.9 | 51.8 | 52.7 | |
Penicillins | 34.4 | 37.3 | 35.6 | |
Macrolides | 5.9 | 1.7 | 4.1 | |
Cephalosporins | 1.5 | 2.5 | 1.9 | |
Sulfonamide | 0.3 | 0.8 | 0.5 | |
Combined therapy, % | ||||
Amoxicillin/Azithromycin | 4.1 | 0.0 | 2.4 | <0.001 |
Cephalosporin/Azithromycin | 0.9 | 5.8 | 2.8 | |
Change of treatment, % | 5.9 | 8.7 | 7.1 | NS |